Annandale Capital »

Leap Therapeutics shares owned by Annandale Capital

Quarter-by-quarter ownership of Leap Therapeutics (LPTX) shares owned by Annandale Capital from 13F filings

Historical chart of Annandale Capital investment in Leap Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Leap Therapeutics held by Annandale Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Leap Therapeutics by Annandale Capital

Quarter filed Position value Share count Share price at filing
2023-09-30 $3.0k 2.0k 1.50

More positions owned by Annandale Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Dimensional Etf Trust Core Fixed Incom (DFCF)
Dimensional Etf Trust Intl Core Eqt Mk (DFAI)
Dimensional Etf Trust Us Core Equity 1 (DCOR)
Dimensional Etf Trust Emgr Cre Eqt Mng (DFAE)
Vanguard Whitehall Fds High Div Yld (VYM)
Meta Platforms Cl A (META)
Ishares Tr Us Treas Bd Etf (GOVT)
Global X Fds Glb X Mlp Enrg I (MLPX)
Uber Technologies (UBER)
Netflix (NFLX)
Ishares Tr Russell 2000 Etf (IWM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Microsoft Corporation (MSFT)

View all positions for Annandale Capital

Top funds holding Leap Therapeutics

Gilead Sciences
Vanguard Group
Acadian Asset Management
HighTower Advisors
Simplify Asset Management
Geode Capital Management
Jane Street
State Street Corporation
BlackRock
Hrt Financial
Two Sigma Advisers
Susquehanna International
Key Client Fiduciary Advisors
Citadel Advisors
Two Sigma Investments

View all funds holding Leap Therapeutics